Selecta Biosciences (NASDAQ:SELB) reported Q1 EPS of $0.23, $0.34 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $34 million versus the consensus estimate of $13.12 million.
Selecta Biosciences (NASDAQ:SELB) reported Q1 EPS of $0.23, $0.34 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $34 million versus the consensus estimate of $13.12 million.